Cardiac stress testing is a vital diagnostic procedure designed to evaluate the heart's response to increased levels of stress and activity. This non-invasive examination is especially useful in assessing the cardiovascular system's performance in individuals suspected of having heart conditions or those deemed at risk for cardiac issues. Whether through treadmill exercise or pharmacological means, patients undergo controlled physical exertion while closely monitored for changes in heart rate, blood pressure, and electrocardiogram (ECG) readings. The primary objective is to induce temporary stress on the heart, simulating the demands of physical activity, in order to identify any abnormalities or limitations in blood flow to the heart muscle. By diagnosing conditions such as coronary artery disease and determining exercise tolerance, cardiac stress testing plays a crucial role in shaping personalized treatment plans and guiding interventions for individuals with concerns related to heart health. The results obtained from this procedure offer valuable insights, aiding healthcare professionals in making informed decisions about patient care and lifestyle recommendations.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation